Contents

Veeva tells Pharmafocus how AI can be used within life sciences sales and marketing
Daiichi Sankyo explores the burden of breast cancer, the impact it has on women and the advances in breast cancer care and precision medicines
PacBio tells considers the use of whole genome sequencing in diagnosing and treating rare diseases, as well as other areas in which this could be utilised
Betsy Goodfellow considers World Mental Health Day and the need for good mental healthcare in autumn and winter

Top News

Page 4Novo Nordisk’s Wegovy (semaglutide injection) made available in the UK
Page 6AstraZeneca and Daiichi Sankyo announce results from DESTINY- Lung02 trial of Enhertu for NSCLC treatment
Page 8MHRA grants marketing authorisation to AbbVie’s Aquipta for migraine prevention
Page 10Sandoz shares exclusive deal to commercialise biosimilar ustekinumab
Page 12Novo Nordisk acquires Embark Biotech

Our Team

Executive Director
PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
Editorial Assistants
Betsy Goodfellow
betsy@pharmafile.com
Sales Manager
Eliot Haynes
Design & Layout
Peter May
Pharmafocus is published by:
Samedan Ltd
Suite E, 11 Bell Yard Mews,
175 Bermondsey Street,
London, SE1 3TN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Subscriptions & Data Management
Curwood CMS Tel: 01580 883840
ISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
©2023 Samedan Ltd, Pharmaceutical Publishers
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.